BUDEPRION - BUPROPION HYDROCHLORIDE
Navigation: NDC > Supplier starting with: T > TEVA PHARMACEUTICALS USA INC| Field | Value |
|---|---|
| NDC Code: | 0093-5351 |
| Proprietary Name: | BUDEPRION |
| Suffix: | XL |
| Non-Proprietary Name: | BUPROPION HYDROCHLORIDE |
| Dosage Form: | TABLET, EXTENDED RELEASE |
| Method: | ORAL |
| Original Marketing Date: | 15-12-2006 |
| End of Marketing: | 30-06-2014 |
| Category Name: | ANDA |
| Application Number: | ANDA077415 |
| Labeler: | TEVA PHARMACEUTICALS USA INC |
| Substance Name: | BUPROPION HYDROCHLORIDE |
| Active Numerator Strength: | 300 |
| Active Ingredient Unit: | mg/1 |
| Pharm Classes: | Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA] |
| DEA Schedule: |